TP53 and hepatocellular carcinoma: Collectively, these findings demonstrate that MVA pathway repression is a crucial component of p53-mediated liver tumor suppression and provides mechanistic insight at the metabolic level as to why and how TP53 gene compromise might benefit HCC progression [2].